Ranitidine Tablets, USP 150 mg, 40 count bottles, NDC 11673-849-40 (Target) OTC.
Recall Number: D-0179-2020
Firm: Dr. Reddy's Laboratories, Inc.
Classification: Class II
Status: Completed
Report Date: 20191113
Initiation Date: 20191001
Termination Date:
Reason for Recall
CGMP Deviations: Presence of NDMA impurity detected in product.
Product Description
Ranitidine Tablets, USP 150 mg, 40 count bottles, NDC 11673-849-40 (Target) OTC.